Loss of NOTCH2 Positively Predicts Survival in Subgroups of Human Glial Brain Tumors
Jean-Louis Boulay , André R. Miserez , Christian Zweifel , Balasubramanian Sivasankaran
PLoS ONE 2 ( 6) e576
59
2007
Prognostic relevance of miRNA-155 methylation in anaplastic glioma
Maximilian Georg Schliesser , Rainer Claus , Thomas Hielscher , Christiane Grimm
Oncotarget 7 ( 50) 82028 -82045
12
2016
Long-term control of disseminated pleomorphic xanthoastrocytoma with anaplastic features by means of stereotactic irradiation
Tomoyuki Koga , Akio Morita , Keisuke Maruyama , Minoru Tanaka
Neuro-oncology 11 ( 4) 446 -451
35
2009
Interferon-β Induces Loss of Spherogenicity and Overcomes Therapy Resistance of Glioblastoma Stem Cells
Caroline Happold , Patrick Roth , Manuela Silginer , Ana-Maria Florea
Molecular Cancer Therapeutics 13 ( 4) 948 -961
31
2014
Aktueller Stand und Perspektiven der Klassifikation von Gliomen
Guido Reifenberger
Onkologe 25 ( 1) 10 -21
2019
Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression.
Julia Reifenberger , Gudrun U. Ring , Ursula Gies , J. M.J. Ludwig Cobbers
Journal of Neuropathology and Experimental Neurology 55 ( 7) 822 -831
161
1996
Identification of Two Distinct Deleted Regions on the Short Arm of Chromosome 1 and Rare Mutation of the CDKN2C Gene from 1p32 in Oligodendroglial Tumors
Kim Husemann , Marietta Wolter , Rainer Büschges , Jan Boström
Journal of Neuropathology and Experimental Neurology 58 ( 10) 1041 -1050
77
1999
Frequent c-myc Amplification in High-Grade Dysplasia and Adenocarcinoma in Barrett Esophagus
Mario Sarbia , Jawed Arjumand , Marietta Wolter , Guido Reifenberger
American Journal of Clinical Pathology 115 ( 6) 835 -840
37
2001
Determination of the proliferative potential of human brain tumors using the monoclonal antibody Ki-67.
Martina Deckert , Guido Reifenberger , Wolfgang Wechsler
Journal of Cancer Research and Clinical Oncology 115 ( 2) 179 -188
88
1989
Case Report: A Case of Severe Clinical Deterioration in a Patient With Multiple Sclerosis.
Katharina Breitkopf , Aykut Aytulun , Moritz Förster , Bastian Kraus
Frontiers in Neurology 11 782
2020
Distribution of anti-Leu-7, anti-Leu-11a and anti-Leu-M1 immunoreactivity in the brain of the adult rat.
Guido Reifenberger , J�rgenK. Mai , Stanislaw Krajewski , Wolfgang Wechsler
Cell and Tissue Research 248 ( 2) 305 -313
37
1987
CSIG-26. MOLECULAR DETERMINANTS OF SENSITIVITY TO PI3K/AKT/mTOR PATHWAY INHIBITION IN GLIOBLASTOMA
Caroline von Achenbach , Michael Weller , Kerstin Kaulich , Dorothee Gramatzki
Neuro-oncology 20
2018
CSIG-27. DIFFERENTIAL ELEVATION OF TERT ACTIVITY AND SENSITIVITY TO TEMOZOLOMIDE BY TYPE OF TERT MUTATION IN MGMT PROMOTER-METHYLATED GLIOBLASTOMA
Manuela Silginer , Alexandros Papachristodolou , Bettina Hentschel , Dorothee Gramatzki
Neuro-oncology 20
2018
DRES-05. MOLECULAR EVOLUTION OF DIFFUSE GLIOMAS AND THE GLIOMA LONGITUDINAL ANALYSIS CONSORTIUM
Roel Verhaak , GLASS Consortium , Kenneth Aldape , Samirkumar Amin
Neuro-oncology 20
2018
RARE-19. CHEMOTHERAPY FOR SPINAL GLIOMAS IN ADULTS: A RETROSPECTIVE STUDY
Dorothee Gramatzki , Jörg Felsberg , Oliver Baehr , Bettina Hentschel
Neuro-oncology 20
2018
BIOL-02. CELLULAR HETEROGENEITY CONTRIBUTES TO THE AGGRESSIVE BEHAVIOR OF MYC-DRIVEN MEDULLOBLASTOMA
Nan Qin , Maike Langini , Daniel Picard , Eunice Paisana
Neuro-oncology 21
2019
ATRT-07. TARGETING PRIMARY CILIOGENESIS IN ATYPICAL TERATOID/RHABDOID TUMORS
Lena Blümel , Kornelius Kerl , Nan Qin , Johannes Berlandi
Neuro-oncology 21
2019
EPEN-08. PHARMACOGENOMICS REVEALS ERBB2 AS A THERAPEUTIC TARGET IN PRIMARY EPENDYMOMA CULTURES
David Pauck , Sevgi Sarikaya-Seiwert , Viktoria Marquardt , Eunice Paisana
Neuro-oncology 21
2019
SIG-03. HHIP-AS1 PROMOTES TUMOR SURVIVAL THROUGH STABILIZING DYNEIN COMPLEX 1 IN HEDGEHOG DRIVEN HUMAN BRAIN TUMORS
Jasmin Bartl , Antoine Forget , Marco Zanini , Daniel Picard
Neuro-oncology 21
2019
ACTR-53. MGMT PROMOTER METHYLATION ANALYSIS FOR ALLOCATING COMBINED CCNU/TMZ CHEMOTHERAPY: LESSONS LEARNED FROM THE CeTeG/NOA-09 TRIAL
Theophilos Tzaridis , Niklas Schäfer , Johannes Weller , Joachim Steinbach
Neuro-oncology 21
2019